Clinical Trial Update: Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for BT8009-230 in metastatic urothelial cancer shows ongoing Phase 2 and Phase 3 studies. The current status is Active, not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• BT8009-230

Snippet

Sponsor: BicycleTx Limited | Conditions: Metastatic Urothelial Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING